209 related articles for article (PubMed ID: 512581)
1. Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2).
Young WW; MacDonald EM; Nowinski RC; Hakomori SI
J Exp Med; 1979 Oct; 150(4):1008-19. PubMed ID: 512581
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody directed to a Hanganutziu-Deicher active ganglioside, GM2 (NeuGc).
Sanai Y; Yamasaki M; Nagai Y
Biochim Biophys Acta; 1988 Feb; 958(3):368-74. PubMed ID: 2449247
[TBL] [Abstract][Full Text] [Related]
3. Preparation of monoclonal antibodies against a glycolipid asialo GM1.
Shimada S; Iwata D
Microbiol Immunol; 1987; 31(9):923-33. PubMed ID: 3696009
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG.
Shitara K; Fujiwara K; Igarashi S; Ohta S; Furuya A; Nakamura K; Koike M; Hanai N
J Immunol Methods; 1994 Feb; 169(1):83-92. PubMed ID: 8133075
[TBL] [Abstract][Full Text] [Related]
5. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.
Livingston PO; Ritter G; Srivastava P; Padavan M; Calves MJ; Oettgen HF; Old LJ
Cancer Res; 1989 Dec; 49(24 Pt 1):7045-50. PubMed ID: 2582446
[TBL] [Abstract][Full Text] [Related]
6. T cell-independent B cell response to self-monosialogangliosides: primary response monoclonal antibodies.
Alfonso M; Vázquez AM; Carr A; Haerslev T; Fernández LE; Lanio ME; Alvarez C; Zeuthen J; Pérez R
Hybridoma; 1995 Jun; 14(3):209-16. PubMed ID: 7590782
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody with reactivity to asialo GM1 and murine natural killer cells.
Solomon FR; Higgins TJ
Mol Immunol; 1987 Jan; 24(1):57-65. PubMed ID: 3614206
[TBL] [Abstract][Full Text] [Related]
8. Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides.
Miyake M; Ito M; Hitomi S; Ikeda S; Taki T; Kurata M; Hino A; Miyake N; Kannagi R
Cancer Res; 1988 Nov; 48(21):6154-60. PubMed ID: 3167861
[TBL] [Abstract][Full Text] [Related]
9. Murine antibody response to the glycolipid asialo GM1 adsorbed to Salmonella.
Higgins TJ
Mol Immunol; 1985 Nov; 22(11):1265-71. PubMed ID: 4079945
[TBL] [Abstract][Full Text] [Related]
10. Novel lacto-ganglio type gangliosides with GM2-epitope in bovine brain which react with IgM from a patient of the amyotrophic lateral sclerosis-like disorder.
Nakao T; Kon K; Ando S; Miyatake T; Yuki N; Li YT; Furuya S; Hirabayashi Y
J Biol Chem; 1993 Oct; 268(28):21028-34. PubMed ID: 7691804
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells.
Kannagi R; Stroup R; Cochran NA; Urdal DL; Young WW; Hakomori S
Cancer Res; 1983 Oct; 43(10):4997-5005. PubMed ID: 6860431
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2).
Krivan HC; Ginsburg V; Roberts DD
Arch Biochem Biophys; 1988 Jan; 260(1):493-6. PubMed ID: 3124753
[TBL] [Abstract][Full Text] [Related]
13. Decreased glycolipid antigen expression in lymphoma cell variants escaping from anti-glycolipid serotherapy.
Young WW; Tamura Y; Johnson HS; Miller DA
J Exp Med; 1983 Jan; 157(1):24-33. PubMed ID: 6848617
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy.
Ilyas AA; Li SC; Chou DK; Li YT; Jungalwala FB; Dalakas MC; Quarles RH
J Biol Chem; 1988 Mar; 263(9):4369-73. PubMed ID: 2450092
[TBL] [Abstract][Full Text] [Related]
15. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.
Ritter G; Fortunato SR; Cohen L; Noguchi Y; Bernard EM; Stockert E; Old LJ
Int J Cancer; 1996 Apr; 66(2):184-90. PubMed ID: 8603809
[TBL] [Abstract][Full Text] [Related]
16. Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient.
Yamaguchi H; Furukawa K; Fortunato SR; Livingston PO; Lloyd KO; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1990 May; 87(9):3333-7. PubMed ID: 2159145
[TBL] [Abstract][Full Text] [Related]
17. Liposome agglutination and liposomal membrane immune-damage assays for the characterization of antibodies to glycosphingolipids.
Uemura K; Yuzawa-Watanabe M; Kitazawa N; Taketomi T
J Biochem; 1980 Jun; 87(6):1641-8. PubMed ID: 7190563
[TBL] [Abstract][Full Text] [Related]
18. A kinetics approach to the characterization of an IgM specific for the glycolipid asialo-GM1.
Harrison BA; MacKenzie R; Hirama T; Lee KK; Altman E
J Immunol Methods; 1998 Mar; 212(1):29-39. PubMed ID: 9671150
[TBL] [Abstract][Full Text] [Related]
19. Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells.
Livingston PO; Calves MJ; Natoli EJ
J Immunol; 1987 Mar; 138(5):1524-9. PubMed ID: 3805726
[TBL] [Abstract][Full Text] [Related]
20. Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells.
Young WW; Hakomori SI; Durdik JM; Henney CS
J Immunol; 1980 Jan; 124(1):199-201. PubMed ID: 6985637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
